Category: Indiwari Gopallawa

Recent Advances in mRNA-based Cancer Vaccines

Reading time: 4 minutes Indiwari Gopallawa After years of seminal research work, mRNA technology got its moment as a result of the Covid-19 pandemic. However, mRNA-based cancer vaccines remain a relatively new and untapped class of vaccines that show great potential. The enthusiasm for this novel technology has been increasing due to recently published experimental... Continue Reading →

0

Non-small cell lung cancer and immunotherapy

Reading time: 4 minutes Indiwari Gopallawa Cancer is the second leading cause of death after cardiovascular diseases in the United States and has a major impact on society. Lung cancer is the second most common cancer type and is associated with lower survival rates and higher cancer-related deaths, accounting for 25% of all cancer-related deaths... Continue Reading →

1

Create a website or blog at WordPress.com

Up ↑